Shinde Arvind M, Dashti Azadeh
Department of Hematology and Oncology, Samuel Oschin Cancer Center, 8700 Beverly Blvd, AC1045, Los Angeles, CA, 90048, USA.
Department of Medicine, Supportive Care Medicine Program, Cedars Sinai Medical Center, Becker Bldg., B224, 8700 Beverly Blvd, Los Angeles, CA, 90048, USA.
Cancer Treat Res. 2016;170:225-50. doi: 10.1007/978-3-319-40389-2_11.
Lung cancer is the most common cancer worldwide and is the leading cause of cancer death for both men and women in the USA. Symptom burden in patients with advanced lung cancer is very high and has a negative impact on their quality of life (QOL). Palliative care with its focus on the management of symptoms and addressing physical, psychosocial, spiritual, and existential suffering, as well as medically appropriate goal setting and open communication with patients and families, significantly adds to the quality of care received by advanced lung cancer patients. The Provisional Clinical Opinion (PCO) of American Society of Clinical Oncology (ASCO) as well as the National Cancer Care Network's (NCCN) clinical practice guidelines recommends early integration of palliative care into routine cancer care. In this chapter, we will provide an overview of palliative care in lung cancer and will examine the evidence and recommendations with regard to a comprehensive and interdisciplinary approach to symptom management, as well as discussions of goals of care, advance care planning, and care preferences.
肺癌是全球最常见的癌症,也是美国男性和女性癌症死亡的主要原因。晚期肺癌患者的症状负担非常高,对他们的生活质量(QOL)有负面影响。姑息治疗专注于症状管理以及解决身体、心理社会、精神和生存方面的痛苦,以及进行医学上适当的目标设定并与患者及其家属进行开放沟通,显著提高了晚期肺癌患者所接受的护理质量。美国临床肿瘤学会(ASCO)的临时临床意见(PCO)以及国家综合癌症网络(NCCN)的临床实践指南都建议将姑息治疗尽早纳入常规癌症护理。在本章中,我们将概述肺癌的姑息治疗,并审视关于症状管理的全面跨学科方法的证据和建议,以及护理目标、预先护理规划和护理偏好的讨论。